2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502

Vol. 51 (2017) N. 6

769-771 D.V. Kuprash, F.Yu. Garib, S.A. Nedospasov "Antibody-Based Drugs and Other Recombinant Proteins for Diagnostics and Therapy of Viral Infections, Autoimmune Diseases and Cancer"

772-781 A.A. Lugovskoy "Engineering Antibodies as Drugs: Principles and Practice"

782-787 A.A. Lushova, M.G. Biazrova, A.G. Prilipov, G.K. Sadykova, T.A. Kopylov, A.V. Filatov "Next-Generation Techniques for Discovering Human Monoclonal Antibodies"

788-803 S.M. Deyev, E.N. Lebedenko "Targeted Bifunctional Proteins and Hybrid Nanoconstructs for Cancer Diagnostics and Therapies"

804-812 V.V. Argentova, T.K. Aliev, V.V. Zarubaev, S.A. Klotchenko, A.A. Shtro, M.V. Sergeeva, V.A. Toporova, D.A. Dolgikh, P.G. Sveshnikov, A.V. Vasin, M.P. Kirpichnikov "In vitro Antiviral Activity of Recombinant Antibodies of IgG and IgA Isotypes to Hemagglutinin of the Influenza A Virus"

813-818 N.E. Sharanova, J. Ninnemann, M.A. Bondareva, Y.K. Semin, A.V. Nomokonova, A.A. Kruglov "Analysis of the Specificity of IgA Antibodies Produced in the Mouse Small Intestine"

819-829 A.N. Vzorov, L.V. Uryvaev "Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination"

830-839 Yu.A. Mokrushina, S.O. Pipiya, A.V. Stepanova, O.G. Shamborant, V.D. Knorre, I.V. Smirnov, A.G. Gabibov, I.I. Vorobiev "Peculiarities of the Mechanism of Interactions of Catalytic Antibodies with Organophosphorus Substrates"

840-854 V.N. Buneva, G.A. Nevinsky "Exceptional Diversity of Catalytic Antibodies with Varying Activity in the Blood of Autoimmune and Viral Disease Patients"

855-864 O.S. Goryainova, T.I. Ivanova, M.V. Rutovskaya, S.V. Tillib "A Method for the Parallel and Sequential Generation of Single-Domain Antibodies for the Proteomic Analysis of Human Blood Plasma"

865-873 G.M. Proshkina, D.V. Kiseleva, O.N. Shilova, A.V. Ryabova, E.I. Shramova, O.A. Stremovskiy, S.M. Deyev "Bifunctional Toxin DARP-LoPE Based on the HER2-Specific Innovative Module of a Non-Immunoglobulin Scaffold as a Promising Agent for Theranostics"

874-886 A.S. Vdovin, N.A. Bykova, G.A. Efimov "T Lymphocytes with Modified Specificity in the Therapy of Malignant Diseases"

887-899 J.-P. Mach "Recombinant Monoclonal Antibodies, from Tumor Targeting to Cancer Immunotherapy: A Critical Overview"

900-905 O.L. Polanovsky "Antibody Engineering: From the Idea to Its Implementation"

906-920 S.M. Danilov "Conformational Fingerprinting Using Monoclonal Antibodies
(on the Example of Angiotensin I-Converting Enzyme-ACE)

921-926 G.A. Efimov, J.M.H. Raats, R.G.S. Chirivi, J.W.G. van Rosmalen, S.A. Nedospasov "Humanization of Murine Monoclonal anti-hTNF Antibody: The F10 Story"